Huang LT, Cao R, Wang YR, Sun L, et al. Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cancer and optimal maintenance therapy: evidence from a meta-analysis of ran BMC Cancer 2021;21:426.
PMID: 33865364